South Africa: Mpox Cases Rise to Seven in SA After New Infection Recorded in W Cape

WHO
Since early May 2022, cases of mpox have been reported from countries where the disease is not endemic, and continue to be reported in several endemic countries.
15 June 2024
SAnews.gov.za (Tshwane)

The Department of Health has advised people on medication for any health condition to adhere to their treatment, as the number of Mpox cases has risen to seven.

The department has noted that all diagnosed patients have chronic illnesses, suggesting a high probability of immunocompromise, unless adherent to prescribed treatment.

"Treatment adherence can prevent new or worsening health problems, and failure to adhere to your prescriptions can negatively impact the quality of your life," the department said.

The latest confirmed case is a 39-year-old male patient, who was admitted on 28 May 2024 at a local private health facility in Cape Town.

On Thursday, he tested positive for Mpox, formerly known as monkeypox, at a private laboratory.

"The patient presented with extensive lesions and he is RVD (retrovirus disease) positive with unknown CD4," the department said.

The latest patient listed his residential address as Northcliff, Gauteng.

On Thursday, Health Minister Dr Joe Phaahla announced a second death linked to Mpox.

Meanwhile, the department said it was scheduled to receive a batch of Mpox treatment, Tecovirimat, which has been described as effective in preventing morbidity and mortality associated with the disease, especially when initiated within a few days of incubation and diagnosis.

In addition, the department said it was working closely with other stakeholders and will continue with surveillance, contract tracing and health education activities across the country and empower citizens with information to make well-informed health choices.

"The effectiveness of contract tracing and case finding depends on the cooperation and accuracy of information provided by both confirmed and suspected cases."

Some of the common symptoms of Mpox include a rash, which may last for two to four weeks, fever, headache, muscle aches, back pain, low energy and swollen glands or lymph nodes.

The painful rash looks like blisters or sores and can affect the face, palms of the hands, soles of the feet, groin, genital and/or anal regions.

Read the original article on SAnews.gov.za.

Tagged:
Copyright © 2024 SAnews.gov.za. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 600 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.